The research and formulation guidance converge on specific ranges that balance efficacy with safety
This liquid formulation combines two synthetic research peptides that have been investigated in published scientific literature involving peptide chemistry, molecular biology, protein interactions, cellular communication, extracellular matrix research, and experimental laboratory models
GHK-Cu exerts its effects primarily through gene expression modulation, influencing approximately 31% of the human genome by upregulating genes involved in antioxidant responses, DNA repair, protein metabolism, and cellular growth while downregulating inflammatory mediators, fibrinogen synthesis, and pathological processes including cancer metastasis
It is available through physician prescription from licensed compounding pharmacies
Draw slowly and ensure you are pulling the full intended volume
Both adjustments follow the same 12-week frequency schedule as the standard 3.2 mg KLOW dose